Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TF Capital
Pudong, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
TF Capital is a China-based venture capital firm specializing in early-stage and growth investments in the life sciences sector, including biotechnology, pharmaceuticals, therapeutics, diagnostics, medical devices, and healthcare services. It backs preclinical and clinical-stage healthcare companies and has been involved with notable startups such as Zai Lab, Alpha Biopharma, Eccogene, and GenFleet Therapeutics, among others[1][2][3][4][5].
- Modalities
- small moleculesmonoclonal antibodiesgene therapiescell therapiesdiagnosticsmedical devices
- Industry
- Investors
02
Partnerships
Qiming Venture PartnersSequoia Capital ChinaKleiner PerkinsOrbiMedSinopharm CapitalLapam Capital
Beyond the preview
Go deeper on TF Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TF Capital.